These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 7501787)
1. Psychiatric disease and cytomegalovirus viremia in renal transplant recipients. Hibberd PL; Surman OS; Bass M; Tolkoff-Rubin NE; Cosimi AB; Schooley RT; Doran M; Delvecchio A; Rosal M; Rubin R Psychosomatics; 1995; 36(6):561-3. PubMed ID: 7501787 [TBL] [Abstract][Full Text] [Related]
2. [Usefulness of urine and blood cultures for diagnosing cytomegalovirus infection in the kidney transplant recipient]. Reina Prieto J; Bestard Palmer X; Saurina Gomila J; Gascó Company J; Fernández-Baca Gutiérrez del Alamo V; Munar Roca M Rev Clin Esp; 1998 Jan; 198(1):3-6. PubMed ID: 9534340 [TBL] [Abstract][Full Text] [Related]
3. A prospective study of rapid methods of detecting cytomegalovirus in the blood of renal transplant recipients in relation to patient and graft survival. Eriksson BM; Wirgart BZ; Claesson K; Tufveson G; Magnusson G; Tötterman T; Grillner L Clin Transplant; 1996 Dec; 10(6 Pt 1):494-502. PubMed ID: 8996769 [TBL] [Abstract][Full Text] [Related]
4. Clinical and virological monitoring of human cytomegalovirus infection in 294 heart transplant recipients. Grossi P; Minoli L; Percivalle E; Irish W; Vigano M; Gerna G Transplantation; 1995 Mar; 59(6):847-51. PubMed ID: 7701579 [TBL] [Abstract][Full Text] [Related]
5. Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia. Gotti E; Suter F; Baruzzo S; Perani V; Moioli F; Remuzzi G Clin Transplant; 1996 Dec; 10(6 Pt 1):550-5. PubMed ID: 8996777 [TBL] [Abstract][Full Text] [Related]
6. Is determination of PP 65 useful for early diagnosis of cytomegalovirus infection in renal transplantation? Klauser R; Kotzmann H; Wamser P; Braza P; Popov-Kraupp T; Franz M; Traindl O; Watschinger B; Pohanka E; Mühlbacher F Transplant Proc; 1992 Dec; 24(6):2628-30. PubMed ID: 1334587 [No Abstract] [Full Text] [Related]
7. Three-year experience with human cytomegalovirus infections in heart transplant recipients. Grossi P; Revello MG; Minoli L; Percivalle E; Zavattoni M; Poma G; Martinelli L; Gerna G J Heart Transplant; 1990; 9(6):712-9. PubMed ID: 2177498 [TBL] [Abstract][Full Text] [Related]
8. [The usefulness of the shell-vial culture in the diagnosis of cytomegalovirus infection in renal transplantation patients]. Reina J; Blanco I; Munar M; Mari M Enferm Infecc Microbiol Clin; 1998 Dec; 16(10):493-4. PubMed ID: 9919004 [No Abstract] [Full Text] [Related]
9. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease]. Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888 [TBL] [Abstract][Full Text] [Related]
10. Virological diagnosis of cytomegalovirus in renal transplantation: comparison of three diagnostic methods: DNA in plasma by PCR, PP65 leukocytic antigenemia, and viremia. Eckart P; Brouard J; Legoff C; Freymuth F; Duhamel JF; Ryckelynck JP; Hurault De Ligny B Transplant Proc; 1996 Oct; 28(5):2806-7. PubMed ID: 8908069 [No Abstract] [Full Text] [Related]
11. Acquisition of donor strains of cytomegalovirus by renal-transplant recipients. Chou SW N Engl J Med; 1986 May; 314(22):1418-23. PubMed ID: 3010114 [TBL] [Abstract][Full Text] [Related]
12. A prospective evaluation of leflunomide therapy for cytomegalovirus disease in renal transplant recipients. John GT; Manivannan J; Chandy S; Peter S; Fleming DH; Chandy SJ; Balakrishnan N; Krishnamurthy K; Kirubakaran MG; Jacob CK Transplant Proc; 2005 Dec; 37(10):4303-5. PubMed ID: 16387103 [TBL] [Abstract][Full Text] [Related]
13. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay. Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717 [TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus DNA in peripheral blood leukocytes and plasma from bone marrow transplant recipients. Brytting M; Mousavi-Jazi M; Boström L; Larsson M; Lunderberg J; Ljungman P; Ringdén O; Sundqvist VA Transplantation; 1995 Nov; 60(9):961-5. PubMed ID: 7491701 [TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus DNAemia detected with real-time polymerase chain reaction in hematopoietic stem cell transplant patients. Sahin DG; Gunduz E; Kasifoglu N; Akay OM; Us T; Gulbas Z Adv Ther; 2013 Aug; 30(8):784-91. PubMed ID: 23959787 [TBL] [Abstract][Full Text] [Related]
16. Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients. Delgado R; Lumbreras C; Alba C; Pedraza MA; Otero JR; Gómez R; Moreno E; Noriega AR; Payá CV J Clin Microbiol; 1992 Jul; 30(7):1876-8. PubMed ID: 1321171 [TBL] [Abstract][Full Text] [Related]
17. CMV Viremia is associated with a decreased incidence of BKV reactivation after kidney and kidney-pancreas transplantation. Elfadawy N; Flechner SM; Liu X; Schold J; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB Transplantation; 2013 Dec; 96(12):1097-103. PubMed ID: 24056621 [TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of cytomegalovirus viremia in lung transplant recipients. Bailey TC; Buller RS; Ettinger NA; Trulock EP; Gaudreault-Keener M; Langlois TM; Fornoff JE; Cooper JD; Storch GA J Infect Dis; 1995 Apr; 171(4):1006-10. PubMed ID: 7706777 [TBL] [Abstract][Full Text] [Related]
19. Sensitive detection of cytomegalovirus infection in transplant recipients using nucleic acid sequence-based amplification. Blok MJ; Lautenschlager I; Christiaans MH; Van Hooff JP; Goossens VJ; Middeldorp JM; Sillekens P; Höckerstedt K; Bruggeman CA Transplant Proc; 2000 Feb; 32(1):149-51. PubMed ID: 10701002 [No Abstract] [Full Text] [Related]
20. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis. Reischig T; Jindra P; Hes O; Bouda M; Kormunda S; Treska V Transplantation; 2009 Feb; 87(3):436-44. PubMed ID: 19202451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]